Fasting while on a GLP-1: what the guidance says

Two risks, and the first one is low blood sugar

Most people ask whether it is safe to add fasting on top of a GLP-1. The 2025 multi-society advisory, from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association and The Obesity Society, names two concerns and puts them in a particular order.

The first is hypoglycaemia. It states that intermittent fasting may increase the risk of low blood sugar in people with type 2 diabetes who are taking glucose-lowering medication, and in people with type 1 diabetes. If you take insulin or a sulfonylurea, that is the sentence on this page that matters most, and it is a reason to have the conversation with your prescriber before you change anything rather than after.

The second concern is one most people do not anticipate.

In its words, individuals on GLP-1 therapy may also practise unintended intermittent fasting, due to not being hungry. Long periods without sufficient protein or dietary variety can lead to nutritional inadequacy, clinical nutrient deficiencies, loss of fat-free mass, and reduced resting energy expenditure.

That reframes the question. On these drugs, skipping meals is not a discipline you impose, it is a thing that happens to you. Someone who was already fasting and starts a GLP-1 may find their eating window collapsing without any decision being made.

The advisory does not tell people to stop fasting. It says that even when using intermittent fasting, individuals taking GLP-1s should be encouraged to consume meals at regular times of the day.

What the guidance asks for

Regular meal times, not just a window. The concern is total intake and variety, not timing.

Enough protein. The advisory notes targets of 1.2 to 1.7 g per kg have been proposed, and is careful to say proposed rather than established. It also states plainly that increased protein alone is likely inadequate to preserve muscle mass without structured resistance training.

Resistance training. The same advisory says GLP-1s should be prescribed together with a structured exercise programme including strength training at least three times weekly. The American Diabetes Association 2026 standards make a similar point, recommending muscle-strengthening exercise for people on obesity pharmacotherapy and advising clinicians to monitor for protein insufficiency.

Where the guidance genuinely contradicts itself

If you are having a procedure under anaesthesia, this matters more than anything else on this page, and the professional bodies do not agree.

A 2025 US statement recommends fasting for solids for 24 hours, clear liquids only, before procedures requiring anaesthesia. A 2025 UK consensus, endorsed by the Royal College of Anaesthetists among others, takes a different line: continue the drug through the peri-operative period and follow standard fasting guidelines, noting that no data support prolonged fasting times. A 2024 multi-society paper sits between them, saying a 24-hour liquid diet can be used where there is concern about delayed gastric emptying.

The FDA labels side with nobody. Added in late 2024, they report pulmonary aspiration in patients who had residual stomach contents despite reported adherence to preoperative fasting, and state that available data are insufficient to inform recommendations, including whether modifying fasting or pausing the drug would help.

The practical reading: tell your anaesthetist you are on a GLP-1, well before the day. Do not work this out from an app or an article, including this one.

The muscle question, which is less settled than the headlines

You will have read that GLP-1s cost you muscle. The picture is mixed.

The concern is real enough that guidance bodies address it: the European Association for the Study of Obesity notes that a considerable share of the weight reduction on incretins originates from lean mass, and recommends protein and resistance exercise to counter it.

But a 2026 expert consensus statement is more sceptical, saying current evidence does not consistently indicate excess loss of muscle mass or strength that would require additional management steps. It adds that some groups may still be susceptible, naming older people, more severe obesity, diabetes and post-menopausal women. It was produced by a panel whose steering committee was selected by its sponsor, a nutrition company, which is worth knowing when weighing it.

That same consensus is the second document to address fasting directly, and it is more permissive than the advisory: with 93 percent agreement, its panel held that a variety of weight-loss approaches, naming continuous energy restriction and intermittent fasting, can be used equally effectively provided they can be followed and meet requirements for protein, fat, micronutrients and fibre.

What is not disputed is the response either way: protein and resistance training. That is the same answer as for fasting alone, and the same answer as for weight loss by any method.

Claims about this that are simply wrong

A striking amount of what is written about GLP-1s and nutrition cites documents that do not say what they are said to say. Worth knowing if you are reading around this topic.

The ESPEN and EASO sarcopenic obesity consensus is often cited for protein targets on GLP-1s. It contains no mention of GLP-1s, semaglutide, fasting, or any protein target; it is a document about definitions and diagnosis.

A widely shared Lancet paper on muscle is cited as though it were a society position. It is a three-page commentary in a journal section reserved for opinion, not a guideline, and it cannot carry the weight placed on it.

If you are on one and want to fast

Start by telling your prescriber. Not as a formality: these drugs interact with insulin and sulfonylureas in ways that make skipping meals genuinely risky, and dose changes may be needed.

Then watch the direction the advisory actually worries about. If your appetite has fallen enough that you are eating once a day without meaning to, adding a deliberate fasting window on top is compounding something rather than starting it.

Track protein rather than hours. On a GLP-1 the binding constraint is usually getting enough in, not restraining yourself from eating.

And lift something twice or three times a week. It is the one recommendation every document on this page agrees on, whether they mention fasting or not.